NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PATZ1
|
ENSG00000100105.13 | POZ/BTB and AT hook containing zinc finger 1 |
KLF4
|
ENSG00000136826.10 | Kruppel like factor 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
KLF4 | hg19_v2_chr9_-_110251836_110251927 | -0.62 | 1.9e-01 | Click! |
PATZ1 | hg19_v2_chr22_-_31742218_31742350 | -0.15 | 7.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_54372877 | 7.70 |
ENST00000414489.1
|
MYADM
|
myeloid-associated differentiation marker |
chr1_-_160068645 | 5.45 |
ENST00000448417.1
|
IGSF8
|
immunoglobulin superfamily, member 8 |
chr11_+_65686952 | 5.44 |
ENST00000527119.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr1_+_37940153 | 5.25 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
chr19_-_54984354 | 4.64 |
ENST00000301200.2
|
CDC42EP5
|
CDC42 effector protein (Rho GTPase binding) 5 |
chr11_-_67397371 | 4.49 |
ENST00000376693.2
ENST00000301490.4 |
NUDT8
|
nudix (nucleoside diphosphate linked moiety X)-type motif 8 |
chr19_-_10946949 | 4.13 |
ENST00000214869.2
ENST00000591695.1 |
TMED1
|
transmembrane emp24 protein transport domain containing 1 |
chr22_-_43583079 | 4.06 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
chr7_-_1499123 | 4.06 |
ENST00000297508.7
|
MICALL2
|
MICAL-like 2 |
chr19_-_48673552 | 3.92 |
ENST00000536218.1
ENST00000596549.1 |
LIG1
|
ligase I, DNA, ATP-dependent |
chr19_-_14201776 | 3.89 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr22_-_50746027 | 3.81 |
ENST00000425954.1
ENST00000449103.1 |
PLXNB2
|
plexin B2 |
chr17_-_76356148 | 3.73 |
ENST00000587578.1
ENST00000330871.2 |
SOCS3
|
suppressor of cytokine signaling 3 |
chr19_+_45504688 | 3.68 |
ENST00000221452.8
ENST00000540120.1 ENST00000505236.1 |
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B |
chr19_+_7985880 | 3.62 |
ENST00000597584.1
|
SNAPC2
|
small nuclear RNA activating complex, polypeptide 2, 45kDa |
chr22_-_50708781 | 3.61 |
ENST00000449719.2
ENST00000330651.6 |
MAPK11
|
mitogen-activated protein kinase 11 |
chr19_-_663277 | 3.61 |
ENST00000292363.5
|
RNF126
|
ring finger protein 126 |
chr20_+_44637526 | 3.58 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr1_-_1051455 | 3.51 |
ENST00000379339.1
ENST00000480643.1 ENST00000434641.1 ENST00000421241.2 |
C1orf159
|
chromosome 1 open reading frame 159 |
chr2_+_74212073 | 3.50 |
ENST00000441217.1
|
AC073046.25
|
AC073046.25 |
chr9_+_136325089 | 3.44 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
chr19_-_4065730 | 3.41 |
ENST00000601588.1
|
ZBTB7A
|
zinc finger and BTB domain containing 7A |
chr9_-_139581848 | 3.31 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr9_+_140445651 | 3.31 |
ENST00000371443.5
|
MRPL41
|
mitochondrial ribosomal protein L41 |
chr10_+_15001430 | 3.30 |
ENST00000407572.1
|
MEIG1
|
meiosis/spermiogenesis associated 1 |
chr19_-_663171 | 3.29 |
ENST00000606896.1
ENST00000589762.2 |
RNF126
|
ring finger protein 126 |
chr6_+_138188351 | 3.28 |
ENST00000421450.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr6_+_138188551 | 3.26 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr11_+_64008525 | 3.23 |
ENST00000449942.2
|
FKBP2
|
FK506 binding protein 2, 13kDa |
chr19_+_18747775 | 3.22 |
ENST00000300976.4
ENST00000595182.1 ENST00000599006.1 |
KLHL26
|
kelch-like family member 26 |
chr22_-_50699972 | 3.20 |
ENST00000395778.3
|
MAPK12
|
mitogen-activated protein kinase 12 |
chr9_-_139581875 | 3.14 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr11_+_65686728 | 3.12 |
ENST00000312515.2
ENST00000525501.1 |
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr19_+_45349630 | 3.10 |
ENST00000252483.5
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
chr19_-_44172396 | 3.10 |
ENST00000602141.1
ENST00000593939.1 ENST00000599546.1 |
PLAUR
|
plasminogen activator, urokinase receptor |
chr14_-_105647606 | 3.04 |
ENST00000392568.2
|
NUDT14
|
nudix (nucleoside diphosphate linked moiety X)-type motif 14 |
chr11_-_507184 | 3.03 |
ENST00000533410.1
ENST00000354420.2 ENST00000397604.3 ENST00000531149.1 ENST00000356187.5 |
RNH1
|
ribonuclease/angiogenin inhibitor 1 |
chr21_+_47401650 | 3.02 |
ENST00000361866.3
|
COL6A1
|
collagen, type VI, alpha 1 |
chr16_-_30134441 | 3.00 |
ENST00000395200.1
|
MAPK3
|
mitogen-activated protein kinase 3 |
chr5_+_172484377 | 2.98 |
ENST00000523161.1
|
CREBRF
|
CREB3 regulatory factor |
chr1_-_160068465 | 2.97 |
ENST00000314485.7
ENST00000368086.1 |
IGSF8
|
immunoglobulin superfamily, member 8 |
chr19_-_18717627 | 2.97 |
ENST00000392386.3
|
CRLF1
|
cytokine receptor-like factor 1 |
chr6_-_160148356 | 2.95 |
ENST00000401980.3
ENST00000545162.1 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr19_-_2015699 | 2.95 |
ENST00000255608.4
|
BTBD2
|
BTB (POZ) domain containing 2 |
chr8_+_22457100 | 2.94 |
ENST00000409586.3
|
C8orf58
|
chromosome 8 open reading frame 58 |
chr16_-_30134266 | 2.94 |
ENST00000484663.1
ENST00000478356.1 |
MAPK3
|
mitogen-activated protein kinase 3 |
chr21_+_42792442 | 2.92 |
ENST00000398600.2
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr9_+_140317802 | 2.91 |
ENST00000341349.2
ENST00000392815.2 |
NOXA1
|
NADPH oxidase activator 1 |
chr1_-_1850697 | 2.88 |
ENST00000378598.4
ENST00000416272.1 ENST00000310991.3 |
TMEM52
|
transmembrane protein 52 |
chr5_+_131409476 | 2.85 |
ENST00000296871.2
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage) |
chr9_+_130922537 | 2.83 |
ENST00000372994.1
|
C9orf16
|
chromosome 9 open reading frame 16 |
chr16_-_402639 | 2.82 |
ENST00000262320.3
|
AXIN1
|
axin 1 |
chr19_-_6767516 | 2.80 |
ENST00000245908.6
|
SH2D3A
|
SH2 domain containing 3A |
chr16_-_28936007 | 2.80 |
ENST00000568703.1
ENST00000567483.1 |
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2 |
chr19_-_17414179 | 2.77 |
ENST00000594194.1
ENST00000247706.3 |
ABHD8
|
abhydrolase domain containing 8 |
chr16_-_30134524 | 2.76 |
ENST00000395202.1
ENST00000395199.3 ENST00000263025.4 ENST00000322266.5 ENST00000403394.1 |
MAPK3
|
mitogen-activated protein kinase 3 |
chr14_+_94577074 | 2.76 |
ENST00000444961.1
ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27
|
interferon, alpha-inducible protein 27 |
chr7_-_1498962 | 2.76 |
ENST00000405088.4
|
MICALL2
|
MICAL-like 2 |
chr19_+_2096868 | 2.75 |
ENST00000395296.1
ENST00000395301.3 |
IZUMO4
|
IZUMO family member 4 |
chr8_-_144691718 | 2.73 |
ENST00000377579.3
ENST00000433751.1 ENST00000220966.6 |
PYCRL
|
pyrroline-5-carboxylate reductase-like |
chr17_+_81037473 | 2.68 |
ENST00000320095.7
|
METRNL
|
meteorin, glial cell differentiation regulator-like |
chr11_-_795400 | 2.65 |
ENST00000526152.1
ENST00000456706.2 ENST00000528936.1 |
SLC25A22
|
solute carrier family 25 (mitochondrial carrier: glutamate), member 22 |
chr9_+_19408919 | 2.63 |
ENST00000380376.1
|
ACER2
|
alkaline ceramidase 2 |
chr22_-_50746001 | 2.63 |
ENST00000359337.4
|
PLXNB2
|
plexin B2 |
chr19_-_30205963 | 2.62 |
ENST00000392278.2
|
C19orf12
|
chromosome 19 open reading frame 12 |
chr2_+_242673994 | 2.62 |
ENST00000321264.4
ENST00000537090.1 ENST00000403782.1 ENST00000342518.6 |
D2HGDH
|
D-2-hydroxyglutarate dehydrogenase |
chr1_-_9189144 | 2.60 |
ENST00000414642.2
|
GPR157
|
G protein-coupled receptor 157 |
chr19_+_56111680 | 2.60 |
ENST00000301073.3
|
ZNF524
|
zinc finger protein 524 |
chr9_+_91150016 | 2.59 |
ENST00000375854.3
ENST00000375855.3 |
NXNL2
|
nucleoredoxin-like 2 |
chr19_+_50887585 | 2.59 |
ENST00000440232.2
ENST00000601098.1 ENST00000599857.1 ENST00000593887.1 |
POLD1
|
polymerase (DNA directed), delta 1, catalytic subunit |
chr11_-_407103 | 2.57 |
ENST00000526395.1
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr22_+_31477296 | 2.57 |
ENST00000426927.1
ENST00000440425.1 ENST00000358743.1 ENST00000347557.2 ENST00000333137.7 |
SMTN
|
smoothelin |
chr19_-_44172467 | 2.57 |
ENST00000599892.1
|
PLAUR
|
plasminogen activator, urokinase receptor |
chr15_+_31658349 | 2.55 |
ENST00000558844.1
|
KLF13
|
Kruppel-like factor 13 |
chr19_+_17830051 | 2.55 |
ENST00000594625.1
ENST00000324096.4 ENST00000600186.1 ENST00000597735.1 |
MAP1S
|
microtubule-associated protein 1S |
chr5_-_176924562 | 2.54 |
ENST00000359895.2
ENST00000355572.2 ENST00000355841.2 ENST00000393551.1 ENST00000505074.1 ENST00000356618.4 ENST00000393546.4 |
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr5_-_150460914 | 2.53 |
ENST00000389378.2
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr11_+_65082289 | 2.53 |
ENST00000279249.2
|
CDC42EP2
|
CDC42 effector protein (Rho GTPase binding) 2 |
chr11_+_64009072 | 2.53 |
ENST00000535135.1
ENST00000394540.3 |
FKBP2
|
FK506 binding protein 2, 13kDa |
chr1_+_44457261 | 2.52 |
ENST00000372318.3
|
CCDC24
|
coiled-coil domain containing 24 |
chr19_+_41305330 | 2.52 |
ENST00000593972.1
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2 |
chr19_-_10946871 | 2.52 |
ENST00000589638.1
|
TMED1
|
transmembrane emp24 protein transport domain containing 1 |
chr17_+_77020325 | 2.51 |
ENST00000311661.4
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chrX_-_153744434 | 2.50 |
ENST00000369643.1
ENST00000393572.1 |
FAM3A
|
family with sequence similarity 3, member A |
chr10_-_135090338 | 2.49 |
ENST00000415217.3
|
ADAM8
|
ADAM metallopeptidase domain 8 |
chr16_+_2039946 | 2.49 |
ENST00000248121.2
ENST00000568896.1 |
SYNGR3
|
synaptogyrin 3 |
chr1_-_2126192 | 2.47 |
ENST00000378546.4
|
C1orf86
|
chromosome 1 open reading frame 86 |
chr17_-_54911250 | 2.47 |
ENST00000575658.1
ENST00000397861.2 |
C17orf67
|
chromosome 17 open reading frame 67 |
chr5_-_1112141 | 2.47 |
ENST00000264930.5
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporter), member 7 |
chr22_-_50968419 | 2.46 |
ENST00000425169.1
ENST00000395680.1 ENST00000395681.1 ENST00000395678.3 ENST00000252029.3 |
TYMP
|
thymidine phosphorylase |
chr7_-_158380371 | 2.44 |
ENST00000389418.4
ENST00000389416.4 |
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
chr10_-_135090360 | 2.41 |
ENST00000486609.1
ENST00000445355.3 ENST00000485491.2 |
ADAM8
|
ADAM metallopeptidase domain 8 |
chr16_-_2246436 | 2.41 |
ENST00000343516.6
|
CASKIN1
|
CASK interacting protein 1 |
chr8_-_145050890 | 2.40 |
ENST00000436759.2
|
PLEC
|
plectin |
chr7_-_559853 | 2.40 |
ENST00000405692.2
|
PDGFA
|
platelet-derived growth factor alpha polypeptide |
chr2_+_235860690 | 2.40 |
ENST00000416021.1
|
SH3BP4
|
SH3-domain binding protein 4 |
chr17_-_79479789 | 2.40 |
ENST00000571691.1
ENST00000571721.1 ENST00000573283.1 ENST00000575842.1 ENST00000575087.1 ENST00000570382.1 ENST00000331925.2 |
ACTG1
|
actin, gamma 1 |
chr9_+_140500087 | 2.39 |
ENST00000371421.4
|
ARRDC1
|
arrestin domain containing 1 |
chr20_+_44462749 | 2.36 |
ENST00000372541.1
|
SNX21
|
sorting nexin family member 21 |
chr19_+_7985198 | 2.36 |
ENST00000221573.6
ENST00000595637.1 |
SNAPC2
|
small nuclear RNA activating complex, polypeptide 2, 45kDa |
chr21_+_42733870 | 2.34 |
ENST00000330714.3
ENST00000436410.1 ENST00000435611.1 |
MX2
|
myxovirus (influenza virus) resistance 2 (mouse) |
chr10_+_104155450 | 2.33 |
ENST00000471698.1
ENST00000189444.6 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr16_-_90085824 | 2.33 |
ENST00000002501.6
|
DBNDD1
|
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
chr9_-_35658007 | 2.33 |
ENST00000602361.1
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease |
chr9_+_130911723 | 2.32 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
chr14_+_103589789 | 2.31 |
ENST00000558056.1
ENST00000560869.1 |
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr16_-_431936 | 2.29 |
ENST00000250930.3
ENST00000431232.2 |
TMEM8A
|
transmembrane protein 8A |
chr10_-_135171510 | 2.29 |
ENST00000278025.4
ENST00000368552.3 |
FUOM
|
fucose mutarotase |
chr16_+_89894875 | 2.27 |
ENST00000393062.2
|
SPIRE2
|
spire-type actin nucleation factor 2 |
chr19_-_46000251 | 2.26 |
ENST00000590526.1
ENST00000344680.4 ENST00000245923.4 |
RTN2
|
reticulon 2 |
chr19_+_49617581 | 2.26 |
ENST00000391864.3
|
LIN7B
|
lin-7 homolog B (C. elegans) |
chr22_-_50700140 | 2.25 |
ENST00000215659.8
|
MAPK12
|
mitogen-activated protein kinase 12 |
chr11_+_560956 | 2.25 |
ENST00000397582.3
ENST00000344375.4 ENST00000397583.3 |
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
chr22_-_50970566 | 2.25 |
ENST00000405135.1
ENST00000401779.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr19_+_36266417 | 2.23 |
ENST00000378944.5
ENST00000007510.4 |
ARHGAP33
|
Rho GTPase activating protein 33 |
chr6_+_144471643 | 2.23 |
ENST00000367568.4
|
STX11
|
syntaxin 11 |
chr11_-_795286 | 2.23 |
ENST00000533385.1
ENST00000527723.1 |
SLC25A22
|
solute carrier family 25 (mitochondrial carrier: glutamate), member 22 |
chr19_-_1174226 | 2.23 |
ENST00000587024.1
ENST00000361757.3 |
SBNO2
|
strawberry notch homolog 2 (Drosophila) |
chr1_+_44457441 | 2.21 |
ENST00000466180.1
|
CCDC24
|
coiled-coil domain containing 24 |
chr11_+_64052692 | 2.20 |
ENST00000377702.4
|
GPR137
|
G protein-coupled receptor 137 |
chr19_-_18632861 | 2.20 |
ENST00000262809.4
|
ELL
|
elongation factor RNA polymerase II |
chr16_+_88519669 | 2.19 |
ENST00000319555.3
|
ZFPM1
|
zinc finger protein, FOG family member 1 |
chr21_-_45196326 | 2.18 |
ENST00000291568.5
|
CSTB
|
cystatin B (stefin B) |
chr19_+_13228917 | 2.17 |
ENST00000586171.1
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing |
chr19_+_56652643 | 2.17 |
ENST00000586123.1
|
ZNF444
|
zinc finger protein 444 |
chr2_-_241836298 | 2.16 |
ENST00000414499.1
|
C2orf54
|
chromosome 2 open reading frame 54 |
chr20_-_17662705 | 2.16 |
ENST00000455029.2
|
RRBP1
|
ribosome binding protein 1 |
chr10_+_135192695 | 2.16 |
ENST00000368539.4
ENST00000278060.5 ENST00000357296.3 |
PAOX
|
polyamine oxidase (exo-N4-amino) |
chrX_+_153238220 | 2.16 |
ENST00000425274.1
|
TMEM187
|
transmembrane protein 187 |
chr14_+_105957402 | 2.16 |
ENST00000421892.1
ENST00000334656.7 ENST00000451719.1 ENST00000392522.3 ENST00000392523.4 ENST00000354560.6 ENST00000450383.1 |
C14orf80
|
chromosome 14 open reading frame 80 |
chr12_-_102133191 | 2.15 |
ENST00000392924.1
ENST00000266743.2 ENST00000392927.3 |
SYCP3
|
synaptonemal complex protein 3 |
chr7_+_22766766 | 2.15 |
ENST00000426291.1
ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6
|
interleukin 6 (interferon, beta 2) |
chr17_+_37821593 | 2.15 |
ENST00000578283.1
|
TCAP
|
titin-cap |
chr8_-_145016692 | 2.15 |
ENST00000357649.2
|
PLEC
|
plectin |
chr22_+_39868786 | 2.15 |
ENST00000429402.1
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
chr2_-_242447962 | 2.15 |
ENST00000405883.3
|
STK25
|
serine/threonine kinase 25 |
chr14_-_105635090 | 2.14 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
chr20_-_34542548 | 2.14 |
ENST00000305978.2
|
SCAND1
|
SCAN domain containing 1 |
chr12_+_132379160 | 2.13 |
ENST00000321867.4
|
ULK1
|
unc-51 like autophagy activating kinase 1 |
chr11_+_66624527 | 2.13 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr16_-_838329 | 2.13 |
ENST00000563560.1
ENST00000569601.1 ENST00000565809.1 ENST00000565377.1 ENST00000007264.2 ENST00000567114.1 |
RPUSD1
|
RNA pseudouridylate synthase domain containing 1 |
chr8_+_144798429 | 2.13 |
ENST00000338033.4
ENST00000395107.4 ENST00000395108.2 |
MAPK15
|
mitogen-activated protein kinase 15 |
chr5_-_176900610 | 2.12 |
ENST00000477391.2
ENST00000393565.1 ENST00000309007.5 |
DBN1
|
drebrin 1 |
chr16_+_89894911 | 2.12 |
ENST00000378247.3
ENST00000563972.1 |
SPIRE2
|
spire-type actin nucleation factor 2 |
chr16_+_32264645 | 2.12 |
ENST00000569631.1
ENST00000354614.3 |
TP53TG3D
|
TP53 target 3D |
chr19_-_55865908 | 2.12 |
ENST00000590900.1
|
COX6B2
|
cytochrome c oxidase subunit VIb polypeptide 2 (testis) |
chr1_+_10093188 | 2.11 |
ENST00000377153.1
|
UBE4B
|
ubiquitination factor E4B |
chr19_+_15218180 | 2.11 |
ENST00000342784.2
ENST00000597977.1 ENST00000600440.1 |
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
chr19_-_55672037 | 2.09 |
ENST00000588076.1
|
DNAAF3
|
dynein, axonemal, assembly factor 3 |
chr2_-_26205550 | 2.09 |
ENST00000405914.1
|
KIF3C
|
kinesin family member 3C |
chr19_+_797392 | 2.09 |
ENST00000350092.4
ENST00000349038.4 ENST00000586481.1 ENST00000585535.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
chr15_+_63569785 | 2.08 |
ENST00000380343.4
ENST00000560353.1 |
APH1B
|
APH1B gamma secretase subunit |
chr20_-_3154162 | 2.08 |
ENST00000360342.3
|
LZTS3
|
Homo sapiens leucine zipper, putative tumor suppressor family member 3 (LZTS3), mRNA. |
chr17_-_79791118 | 2.08 |
ENST00000576431.1
ENST00000575061.1 ENST00000455127.2 ENST00000572645.1 ENST00000538396.1 ENST00000573478.1 |
FAM195B
|
family with sequence similarity 195, member B |
chr21_+_42798094 | 2.06 |
ENST00000398598.3
ENST00000455164.2 ENST00000424365.1 |
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr6_-_160114260 | 2.06 |
ENST00000367054.2
ENST00000367055.4 ENST00000444946.2 ENST00000452684.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr22_+_45098067 | 2.05 |
ENST00000336985.6
ENST00000403696.1 ENST00000457960.1 ENST00000361473.5 |
PRR5
PRR5-ARHGAP8
|
proline rich 5 (renal) PRR5-ARHGAP8 readthrough |
chr7_+_2671568 | 2.04 |
ENST00000258796.7
|
TTYH3
|
tweety family member 3 |
chr22_+_38004723 | 2.04 |
ENST00000381756.5
|
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr16_+_3115298 | 2.04 |
ENST00000325568.5
ENST00000534507.1 |
IL32
|
interleukin 32 |
chr14_+_103592636 | 2.03 |
ENST00000333007.1
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr17_-_72869140 | 2.02 |
ENST00000583917.1
ENST00000293195.5 ENST00000442102.2 |
FDXR
|
ferredoxin reductase |
chr11_-_615570 | 2.01 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr19_-_42758040 | 2.00 |
ENST00000593944.1
|
ERF
|
Ets2 repressor factor |
chr9_-_140317605 | 2.00 |
ENST00000479452.1
ENST00000465160.2 |
EXD3
|
exonuclease 3'-5' domain containing 3 |
chr19_+_45349432 | 2.00 |
ENST00000252485.4
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
chr2_+_181845532 | 1.99 |
ENST00000602475.1
|
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
chr1_+_955448 | 1.99 |
ENST00000379370.2
|
AGRN
|
agrin |
chr11_+_65687158 | 1.99 |
ENST00000532933.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr19_+_10381769 | 1.98 |
ENST00000423829.2
ENST00000588645.1 |
ICAM1
|
intercellular adhesion molecule 1 |
chr14_+_105266933 | 1.98 |
ENST00000555360.1
|
ZBTB42
|
zinc finger and BTB domain containing 42 |
chr12_+_6419877 | 1.98 |
ENST00000536531.1
|
PLEKHG6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
chr19_+_532049 | 1.97 |
ENST00000606136.1
|
CDC34
|
cell division cycle 34 |
chr1_+_3689325 | 1.97 |
ENST00000444870.2
ENST00000452264.1 |
SMIM1
|
small integral membrane protein 1 (Vel blood group) |
chr19_-_14201507 | 1.97 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr22_-_50699701 | 1.97 |
ENST00000395780.1
|
MAPK12
|
mitogen-activated protein kinase 12 |
chr2_+_241392227 | 1.96 |
ENST00000420138.1
|
GPC1
|
glypican 1 |
chr17_+_17206635 | 1.96 |
ENST00000389022.4
|
NT5M
|
5',3'-nucleotidase, mitochondrial |
chr1_-_200992827 | 1.96 |
ENST00000332129.2
ENST00000422435.2 |
KIF21B
|
kinesin family member 21B |
chr19_-_1863567 | 1.96 |
ENST00000250916.4
|
KLF16
|
Kruppel-like factor 16 |
chr17_+_73521763 | 1.96 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
chr4_-_82965397 | 1.96 |
ENST00000512716.1
ENST00000514050.1 ENST00000512343.1 ENST00000510780.1 ENST00000508294.1 |
RASGEF1B
RP11-689K5.3
|
RasGEF domain family, member 1B RP11-689K5.3 |
chr17_+_6939362 | 1.96 |
ENST00000308027.6
|
SLC16A13
|
solute carrier family 16, member 13 |
chr16_+_89989687 | 1.95 |
ENST00000315491.7
ENST00000555576.1 ENST00000554336.1 ENST00000553967.1 |
TUBB3
|
Tubulin beta-3 chain |
chr16_+_128062 | 1.95 |
ENST00000356432.3
ENST00000219431.4 |
MPG
|
N-methylpurine-DNA glycosylase |
chr6_+_138188378 | 1.95 |
ENST00000420009.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr17_-_62207485 | 1.94 |
ENST00000433197.3
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1 |
chr19_+_7745708 | 1.93 |
ENST00000596148.1
ENST00000317378.5 ENST00000426877.2 |
TRAPPC5
|
trafficking protein particle complex 5 |
chr19_+_17326141 | 1.93 |
ENST00000445667.2
ENST00000263897.5 |
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr17_+_77020224 | 1.92 |
ENST00000339142.2
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr19_-_1490398 | 1.92 |
ENST00000588671.1
ENST00000300954.5 |
PCSK4
|
proprotein convertase subtilisin/kexin type 4 |
chr19_+_41305085 | 1.92 |
ENST00000303961.4
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2 |
chr11_-_45928830 | 1.92 |
ENST00000449465.1
|
C11orf94
|
chromosome 11 open reading frame 94 |
chr22_-_50970506 | 1.91 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr19_+_35491174 | 1.91 |
ENST00000317991.5
ENST00000504615.2 |
GRAMD1A
|
GRAM domain containing 1A |
chr11_+_64008443 | 1.91 |
ENST00000309366.4
|
FKBP2
|
FK506 binding protein 2, 13kDa |
chr18_+_77794446 | 1.91 |
ENST00000262197.7
|
RBFA
|
ribosome binding factor A (putative) |
chr5_-_176738883 | 1.90 |
ENST00000513169.1
ENST00000423571.2 ENST00000502529.1 ENST00000427908.2 |
MXD3
|
MAX dimerization protein 3 |
chr7_+_100210133 | 1.90 |
ENST00000393950.2
ENST00000424091.2 |
MOSPD3
|
motile sperm domain containing 3 |
chr17_-_72869086 | 1.90 |
ENST00000581530.1
ENST00000420580.2 ENST00000455107.2 ENST00000413947.2 ENST00000581219.1 ENST00000582944.1 |
FDXR
|
ferredoxin reductase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.7 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
2.8 | 8.5 | GO:2000349 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of osteoclast proliferation(GO:0090291) negative regulation of CD40 signaling pathway(GO:2000349) |
2.4 | 7.3 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
2.0 | 5.9 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
1.7 | 5.1 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
1.7 | 8.4 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
1.4 | 11.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.3 | 4.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.3 | 6.6 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
1.3 | 5.2 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
1.2 | 6.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.2 | 4.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
1.2 | 3.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
1.1 | 4.4 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
1.1 | 1.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
1.1 | 5.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.1 | 8.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
1.0 | 3.1 | GO:0003192 | mitral valve formation(GO:0003192) |
1.0 | 5.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
1.0 | 3.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
1.0 | 4.0 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.0 | 4.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
1.0 | 2.9 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
1.0 | 3.9 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
1.0 | 5.9 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
1.0 | 1.0 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
1.0 | 3.8 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
1.0 | 3.8 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.0 | 2.9 | GO:0019516 | lactate oxidation(GO:0019516) |
0.9 | 3.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.9 | 0.9 | GO:0021591 | ventricular system development(GO:0021591) |
0.9 | 6.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.9 | 2.6 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.9 | 4.3 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.8 | 2.5 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.8 | 3.4 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.8 | 2.5 | GO:1990619 | histone H3-K9 deacetylation(GO:1990619) |
0.8 | 2.5 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
0.8 | 1.6 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.8 | 6.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.8 | 3.2 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.8 | 3.1 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.8 | 2.3 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
0.8 | 2.3 | GO:0014028 | notochord formation(GO:0014028) |
0.7 | 3.7 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.7 | 0.7 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 2.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.7 | 1.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.7 | 0.7 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.7 | 2.2 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.7 | 4.2 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.7 | 2.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.7 | 3.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.7 | 4.9 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.7 | 2.1 | GO:1905166 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
0.7 | 4.7 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.7 | 2.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.7 | 2.7 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.7 | 2.0 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.7 | 2.0 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.7 | 2.6 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.7 | 3.9 | GO:0030421 | defecation(GO:0030421) |
0.7 | 2.0 | GO:0035572 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.6 | 1.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.6 | 1.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.6 | 0.6 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.6 | 3.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.6 | 3.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.6 | 3.2 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.6 | 0.6 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.6 | 0.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.6 | 1.9 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.6 | 8.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.6 | 2.5 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.6 | 2.5 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.6 | 1.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.6 | 1.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.6 | 3.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.6 | 1.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.6 | 2.4 | GO:0044691 | tooth eruption(GO:0044691) |
0.6 | 3.6 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.6 | 1.8 | GO:0015743 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.6 | 0.6 | GO:0031033 | myosin filament organization(GO:0031033) |
0.6 | 1.7 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.6 | 1.7 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.6 | 1.7 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.6 | 1.7 | GO:0033122 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.6 | 2.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.6 | 1.7 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.6 | 1.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.6 | 1.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 2.3 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.6 | 2.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.6 | 3.4 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.6 | 2.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.6 | 2.2 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.6 | 2.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.6 | 3.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 2.2 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.5 | 2.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.5 | 0.5 | GO:0032273 | positive regulation of protein polymerization(GO:0032273) |
0.5 | 2.2 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.5 | 1.6 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
0.5 | 1.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 3.7 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.5 | 2.1 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.5 | 1.1 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.5 | 2.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.5 | 3.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.5 | 1.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.5 | 2.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.5 | 2.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.5 | 1.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 1.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 4.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 2.0 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.5 | 0.5 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
0.5 | 10.6 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.5 | 1.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.5 | 3.5 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.5 | 1.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 2.0 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.5 | 1.5 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.5 | 1.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.5 | 5.9 | GO:0060180 | female mating behavior(GO:0060180) |
0.5 | 2.0 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.5 | 0.5 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.5 | 2.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 3.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.5 | 6.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.5 | 1.5 | GO:2001037 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.5 | 2.0 | GO:1903382 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.5 | 1.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.5 | 0.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.5 | 1.5 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.5 | 0.5 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.5 | 1.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.5 | 1.4 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.5 | 1.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.5 | 1.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.5 | 0.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.5 | 2.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.5 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.5 | 0.5 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.5 | 4.7 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.5 | 0.9 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.5 | 0.5 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.5 | 2.8 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.5 | 0.9 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
0.5 | 1.8 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.5 | 1.8 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.5 | 4.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.5 | 0.9 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.5 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.4 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.4 | 2.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 1.3 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.4 | 1.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 2.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.4 | 1.3 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.4 | 1.8 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
0.4 | 0.9 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.4 | 1.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.4 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.4 | 0.9 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.4 | 1.3 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.4 | 1.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 2.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.4 | 1.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.4 | 1.7 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.4 | 9.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 0.4 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.4 | 1.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.4 | 5.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 0.9 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.4 | 0.4 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 1.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 2.1 | GO:0030820 | regulation of cyclic nucleotide catabolic process(GO:0030805) positive regulation of cyclic nucleotide catabolic process(GO:0030807) regulation of cAMP catabolic process(GO:0030820) positive regulation of cAMP catabolic process(GO:0030822) regulation of purine nucleotide catabolic process(GO:0033121) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.4 | 4.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.4 | 0.8 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.4 | 0.8 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.4 | 3.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 0.8 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.4 | 2.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 0.8 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.4 | 2.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 2.0 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.4 | 2.0 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.4 | 0.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 0.4 | GO:1903401 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.4 | 2.4 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.4 | 2.0 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.4 | 1.6 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.4 | 3.2 | GO:0045007 | depurination(GO:0045007) |
0.4 | 2.3 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.4 | 2.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 6.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.4 | 2.3 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.4 | 1.9 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.4 | 5.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 1.1 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.4 | 1.1 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.4 | 1.1 | GO:1903947 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.4 | 1.9 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.4 | 1.1 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.4 | 1.5 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.4 | 0.8 | GO:0001300 | chronological cell aging(GO:0001300) |
0.4 | 2.6 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.4 | 3.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 1.1 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.4 | 0.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.4 | 1.9 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.4 | 1.5 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.4 | 2.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 2.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 1.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 0.4 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.4 | 0.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 1.1 | GO:0032796 | uropod organization(GO:0032796) |
0.4 | 1.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.4 | 0.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.4 | 2.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 5.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 1.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.4 | 1.1 | GO:0052553 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.4 | 0.4 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.4 | 1.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 1.8 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
0.4 | 1.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.4 | 13.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 4.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.3 | 3.5 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.3 | 1.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.3 | 2.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.3 | 1.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 1.7 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.3 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 4.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.3 | 1.7 | GO:0032218 | riboflavin transport(GO:0032218) |
0.3 | 0.3 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.3 | 1.0 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.3 | 0.3 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.3 | 1.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.3 | 0.3 | GO:1901207 | regulation of heart looping(GO:1901207) |
0.3 | 7.0 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.3 | 2.0 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.3 | 7.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 3.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.3 | 1.0 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.3 | 1.3 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.3 | 1.0 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 2.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.3 | 1.3 | GO:0009386 | translational attenuation(GO:0009386) |
0.3 | 1.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.7 | GO:0043311 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) regulation of eosinophil activation(GO:1902566) positive regulation of eosinophil activation(GO:1902568) |
0.3 | 1.3 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.3 | 1.0 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.3 | 2.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.3 | 1.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 0.6 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.3 | 1.0 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.3 | 2.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.3 | 1.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 3.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.3 | 5.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 2.8 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.3 | 1.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.3 | 0.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 1.3 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.3 | 0.9 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 0.6 | GO:0002537 | nitric oxide production involved in inflammatory response(GO:0002537) |
0.3 | 1.6 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 | 0.9 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.3 | 1.3 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.3 | 1.9 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.3 | 1.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.3 | 3.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 1.9 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.3 | 1.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.3 | 2.8 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.3 | 1.5 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.3 | 7.4 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.3 | 0.3 | GO:0070100 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 3.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 5.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 1.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 2.1 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.3 | 3.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 0.9 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.3 | 2.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 1.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 0.9 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.3 | 0.9 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.3 | 0.9 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.3 | 2.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.3 | 6.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 1.2 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.3 | 2.6 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 3.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 0.6 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.3 | 0.9 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.3 | 1.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.3 | 5.8 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 1.7 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.3 | 2.0 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.3 | 2.3 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
0.3 | 2.0 | GO:0045991 | carbon catabolite activation of transcription(GO:0045991) |
0.3 | 0.9 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.3 | 2.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.3 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 1.4 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.3 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.3 | 1.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 0.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 3.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 0.3 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.3 | 1.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 0.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 3.1 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.3 | 0.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 0.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.3 | 0.3 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.3 | 0.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.3 | 0.3 | GO:0051254 | positive regulation of RNA metabolic process(GO:0051254) |
0.3 | 0.8 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.3 | 2.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 3.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 2.2 | GO:0015811 | L-cystine transport(GO:0015811) |
0.3 | 12.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 0.3 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.3 | 0.5 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 1.1 | GO:1903412 | response to bile acid(GO:1903412) |
0.3 | 0.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.3 | 1.1 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.3 | 1.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 2.9 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.3 | 1.6 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.3 | 0.5 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 0.8 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.3 | 0.5 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.3 | 1.3 | GO:0051593 | response to folic acid(GO:0051593) |
0.3 | 2.1 | GO:0044211 | CTP salvage(GO:0044211) |
0.3 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 3.1 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.3 | 6.5 | GO:0030220 | platelet formation(GO:0030220) |
0.3 | 1.0 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.3 | 1.0 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.3 | 2.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 0.3 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.3 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.3 | 2.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.3 | 0.8 | GO:0048627 | myoblast development(GO:0048627) |
0.3 | 3.5 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 1.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 2.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 1.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.5 | GO:0046618 | drug export(GO:0046618) |
0.2 | 2.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 2.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 1.0 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.2 | 0.7 | GO:0072011 | glomerular endothelium development(GO:0072011) |
0.2 | 1.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 2.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 3.2 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.2 | 1.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 6.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.7 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.2 | 0.7 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 4.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 1.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.7 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.2 | 1.2 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 0.2 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) |
0.2 | 1.0 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.2 | 0.5 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
0.2 | 0.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 1.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.2 | 2.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 1.9 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.2 | 1.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 1.2 | GO:0021557 | optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.2 | 0.7 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.2 | 1.0 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.2 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.9 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 0.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.2 | 2.4 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.2 | 1.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.7 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.2 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.2 | 2.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.9 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.2 | 0.5 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.2 | 10.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.2 | 0.5 | GO:0051592 | response to calcium ion(GO:0051592) |
0.2 | 4.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.2 | GO:0032098 | regulation of response to food(GO:0032095) negative regulation of response to food(GO:0032096) regulation of appetite(GO:0032098) negative regulation of appetite(GO:0032099) |
0.2 | 0.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.9 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 2.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 1.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.2 | 1.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.5 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.2 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 2.0 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.2 | 0.2 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.2 | 2.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 2.4 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 2.2 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.2 | 0.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.2 | 0.9 | GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) |
0.2 | 0.9 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.2 | 0.2 | GO:0060532 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.2 | 0.4 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 1.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 2.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 1.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 0.4 | GO:0009644 | response to high light intensity(GO:0009644) |
0.2 | 1.5 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.2 | 0.6 | GO:0031247 | actin rod assembly(GO:0031247) |
0.2 | 3.0 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.2 | 0.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.2 | 0.2 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.2 | 0.2 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.2 | 1.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 0.6 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.2 | 0.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 2.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.3 | GO:0050433 | regulation of catecholamine secretion(GO:0050433) |
0.2 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 0.6 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.2 | 0.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.2 | 0.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 1.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 2.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 3.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.6 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.2 | 1.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.0 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.2 | 0.8 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 1.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 1.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.2 | 1.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 1.0 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.2 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 0.8 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.2 | 0.6 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.2 | 0.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 1.2 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 2.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 2.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 3.6 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.2 | 4.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 1.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 2.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 5.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 1.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.8 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 2.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.2 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.2 | 0.4 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 2.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 2.0 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.4 | GO:1901656 | glycoside transport(GO:1901656) |
0.2 | 1.0 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.2 | 1.9 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.2 | 0.2 | GO:0043132 | NAD transport(GO:0043132) |
0.2 | 0.6 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.2 | 0.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.2 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 0.8 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.2 | 5.0 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.2 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 1.4 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.4 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.2 | 0.8 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.2 | 0.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.2 | 0.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 0.4 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 0.4 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.2 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 2.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.2 | 0.4 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 5.5 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 1.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 1.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.6 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.2 | 0.6 | GO:1900166 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
0.2 | 2.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 3.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.8 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.6 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.2 | 1.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.6 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.2 | 0.4 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.2 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.2 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.2 | 0.6 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.2 | 0.7 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.2 | 0.9 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 1.9 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 2.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 0.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 1.1 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 0.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 0.4 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.2 | 1.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.4 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.2 | 1.6 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 0.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.9 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 2.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 1.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 1.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 0.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.2 | 0.2 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
0.2 | 1.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.2 | 0.2 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.2 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 0.4 | GO:1904894 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.2 | 1.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.2 | 0.2 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.2 | 1.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 1.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 2.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.5 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
0.2 | 2.1 | GO:0007620 | copulation(GO:0007620) |
0.2 | 1.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.4 | GO:0001825 | blastocyst formation(GO:0001825) |
0.2 | 2.6 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 6.0 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 0.9 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.2 | 1.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.7 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.2 | 1.4 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.2 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 17.0 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 0.7 | GO:0015793 | glycerol transport(GO:0015793) |
0.2 | 2.8 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.2 | 0.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.3 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.2 | 2.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 0.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.2 | 1.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 2.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 2.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 1.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.7 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.2 | 0.5 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
0.2 | 1.0 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.2 | 1.2 | GO:0046881 | regulation of follicle-stimulating hormone secretion(GO:0046880) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 0.7 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 1.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.7 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.2 | 1.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.5 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.2 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.2 | 0.7 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.2 | 1.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.5 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 2.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 0.5 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.2 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 1.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 1.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 1.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 9.7 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.2 | 0.6 | GO:0019046 | release from viral latency(GO:0019046) |
0.2 | 2.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.5 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 5.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.5 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.2 | 1.0 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.2 | 1.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 4.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 3.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.8 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.5 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 1.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 0.8 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 0.5 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 1.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.2 | 0.8 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 1.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.5 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.2 | 0.6 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 0.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
0.2 | 0.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.2 | 0.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.9 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.2 | 0.3 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.2 | 0.6 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.2 | 0.6 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 3.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 2.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.9 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.6 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.2 | 2.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.2 | 0.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.2 | 2.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.4 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
0.1 | 1.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.6 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.1 | 0.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 1.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.6 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.1 | 0.6 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.1 | 1.0 | GO:0071450 | response to superoxide(GO:0000303) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.7 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.3 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.3 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 1.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.6 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 0.3 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 1.0 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.4 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.1 | 5.6 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 3.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.9 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.1 | 0.3 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 0.6 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 1.1 | GO:2001235 | positive regulation of apoptotic signaling pathway(GO:2001235) |
0.1 | 1.4 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 1.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.1 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.1 | 1.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.4 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 4.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 3.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 1.0 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 0.3 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.1 | 1.0 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 2.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 5.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.1 | 1.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.6 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 1.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 3.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.1 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.1 | 0.7 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 2.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 2.4 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.1 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.1 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 3.4 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.5 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 1.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 1.2 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
0.1 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 1.5 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 2.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.5 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.8 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.1 | 0.3 | GO:0000578 | embryonic axis specification(GO:0000578) blastoderm segmentation(GO:0007350) |
0.1 | 1.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.5 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.1 | 0.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.1 | 0.7 | GO:1904141 | mammary gland fat development(GO:0060611) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
0.1 | 2.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 1.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 1.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.3 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.1 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 1.2 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.3 | GO:1901983 | regulation of histone acetylation(GO:0035065) regulation of protein acetylation(GO:1901983) |
0.1 | 0.7 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.1 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.3 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.7 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.1 | GO:0060541 | respiratory system development(GO:0060541) |
0.1 | 0.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.1 | 1.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.4 | GO:0048687 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.4 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.1 | 0.3 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 1.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.9 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 1.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 1.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 3.2 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 3.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 1.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.9 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.8 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 1.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 1.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 1.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 1.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.4 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.2 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 1.6 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.4 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 1.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 1.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.1 | GO:1904783 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.1 | 0.1 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 1.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.5 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 3.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.1 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.1 | 0.4 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.1 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.4 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 1.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.6 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 1.1 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.1 | 1.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 1.7 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.4 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.1 | 1.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 3.6 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.4 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.1 | 0.4 | GO:0010934 | macrophage cytokine production(GO:0010934) |
0.1 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.6 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 0.4 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 0.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.1 | 1.7 | GO:0007567 | parturition(GO:0007567) |
0.1 | 1.1 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 2.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0072034 | astrocyte fate commitment(GO:0060018) renal vesicle induction(GO:0072034) |
0.1 | 0.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.3 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.1 | 0.5 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.7 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.5 | GO:0006868 | glutamine transport(GO:0006868) glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 0.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 1.2 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 2.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.1 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.1 | 3.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.1 | 0.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.3 | GO:0044209 | AMP salvage(GO:0044209) |
0.1 | 0.5 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.3 | GO:0061026 | central nervous system morphogenesis(GO:0021551) cardiac muscle tissue regeneration(GO:0061026) |
0.1 | 0.3 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.1 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.1 | 0.1 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.6 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 1.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 2.7 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 7.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.3 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.4 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.1 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.2 | GO:0046075 | dTTP metabolic process(GO:0046075) |
0.1 | 0.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 1.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.9 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.8 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 3.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0014032 | neural crest cell development(GO:0014032) |
0.1 | 0.3 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 1.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.2 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.1 | 7.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 1.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.2 | GO:0055007 | cardiac muscle cell differentiation(GO:0055007) |
0.1 | 0.1 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.1 | 0.4 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.5 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.3 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.4 | GO:0044053 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
0.1 | 1.8 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.2 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 1.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.3 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.1 | 0.3 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.1 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.1 | 1.6 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 1.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.4 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.1 | 0.2 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.5 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.1 | 0.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 0.5 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.1 | 0.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 5.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 1.6 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 1.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.5 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.3 | GO:0002664 | lymphocyte anergy(GO:0002249) regulation of T cell tolerance induction(GO:0002664) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.2 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.1 | 0.3 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.2 | GO:0097477 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
0.1 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.1 | 1.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.2 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
0.1 | 0.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 1.8 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 2.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 4.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 1.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:0071529 | cementum mineralization(GO:0071529) |
0.1 | 1.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.3 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.4 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.1 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.1 | GO:0051262 | protein tetramerization(GO:0051262) |
0.1 | 10.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.3 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 1.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.1 | 0.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 0.5 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.1 | 0.9 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.1 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.8 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.1 | 0.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.4 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.1 | 0.5 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.4 | GO:0036269 | swimming behavior(GO:0036269) |
0.1 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 3.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.1 | 0.3 | GO:0021503 | neural fold bending(GO:0021503) |
0.1 | 1.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 1.0 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.6 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 0.4 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.1 | 0.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 2.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 1.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.1 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.2 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.1 | 0.6 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 1.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 2.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.5 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:0048749 | compound eye development(GO:0048749) |
0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.3 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.5 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 1.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 0.3 | GO:0032207 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.1 | 0.3 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.3 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.1 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 5.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 1.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.1 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.1 | 0.6 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:2000506 | negative regulation of energy homeostasis(GO:2000506) |
0.1 | 0.3 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.1 | 0.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 2.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.3 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 6.9 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 2.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 7.9 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.1 | 0.5 | GO:0036301 | interleukin-21 production(GO:0032625) macrophage colony-stimulating factor production(GO:0036301) interleukin-21 secretion(GO:0072619) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.1 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 1.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.1 | 2.9 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 2.2 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.1 | 0.2 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 0.3 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 1.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 2.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.2 | GO:0097535 | striatal medium spiny neuron differentiation(GO:0021773) post-embryonic camera-type eye development(GO:0031077) lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 0.8 | GO:0007507 | heart development(GO:0007507) |
0.1 | 0.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.1 | 0.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.5 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 1.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.1 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.6 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 5.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 1.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.8 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.3 | GO:0016598 | protein arginylation(GO:0016598) |
0.1 | 1.0 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.1 | 0.1 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 1.7 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.3 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.6 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.2 | GO:2000521 | regulation of immunological synapse formation(GO:2000520) negative regulation of immunological synapse formation(GO:2000521) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.3 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.1 | GO:0033590 | response to cobalamin(GO:0033590) |
0.1 | 1.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.4 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.8 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.4 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.1 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 0.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 2.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 1.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.1 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.1 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 0.1 | GO:0048806 | genitalia development(GO:0048806) |
0.1 | 0.1 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
0.1 | 0.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 1.0 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.4 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 1.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 3.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 1.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 1.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.2 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.3 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 1.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:1901159 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.1 | 0.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.9 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.1 | GO:0006863 | purine nucleobase transport(GO:0006863) |
0.1 | 0.3 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 3.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 2.7 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0019318 | hexose metabolic process(GO:0019318) |
0.1 | 1.8 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.1 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 2.0 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.1 | 1.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 1.1 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.1 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
0.1 | 0.1 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.1 | GO:0048562 | embryonic organ morphogenesis(GO:0048562) |
0.1 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 1.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 0.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.3 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.1 | 0.1 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.1 | 0.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.1 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.1 | 0.2 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.4 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 0.7 | GO:1900076 | regulation of cellular response to insulin stimulus(GO:1900076) |
0.1 | 0.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.6 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 2.1 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.6 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.7 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.1 | GO:0034059 | response to anoxia(GO:0034059) |
0.1 | 0.1 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.1 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.1 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 0.2 | GO:0052361 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.1 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 1.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 0.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.1 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 1.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.1 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.1 | 1.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 1.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 1.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 1.4 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.3 | GO:0001701 | in utero embryonic development(GO:0001701) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.1 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 2.3 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.2 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.1 | 0.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 4.7 | GO:0006901 | vesicle coating(GO:0006901) |
0.1 | 0.8 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 0.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.7 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.1 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 1.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.5 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.4 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.2 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.1 | 0.2 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.1 | 0.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.2 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 0.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 3.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) cristae formation(GO:0042407) |
0.1 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 3.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.1 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 0.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.2 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.1 | 0.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 0.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.4 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 4.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.8 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.0 | 1.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.0 | 0.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.0 | 0.1 | GO:0001743 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.0 | 0.0 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.0 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 1.9 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.0 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 1.5 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.0 | 0.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.7 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.0 | 0.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0034698 | response to gonadotropin(GO:0034698) |
0.0 | 1.7 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.1 | GO:0007254 | JNK cascade(GO:0007254) |
0.0 | 0.3 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.0 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.0 | 0.2 | GO:0003335 | corneocyte development(GO:0003335) |
0.0 | 0.0 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.1 | GO:0019075 | virus maturation(GO:0019075) |
0.0 | 0.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.0 | 0.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 0.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.3 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.6 | GO:0014870 | response to muscle inactivity(GO:0014870) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.0 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.0 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 3.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.3 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.0 | 0.5 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.1 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.1 | GO:0007210 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.0 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.0 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.0 | 0.1 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.1 | GO:0008211 | glucocorticoid biosynthetic process(GO:0006704) glucocorticoid metabolic process(GO:0008211) |
0.0 | 3.9 | GO:0009566 | fertilization(GO:0009566) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.2 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.0 | 2.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.2 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.0 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.0 | 0.4 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 4.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.2 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.0 | 0.0 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.3 | GO:0043306 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.0 | 0.1 | GO:0021997 | neural plate axis specification(GO:0021997) |
0.0 | 0.8 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.1 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.0 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 1.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.0 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.0 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.0 | 0.2 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.0 | 0.1 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 0.9 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.2 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.0 | 0.0 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.0 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 1.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.0 | GO:0071435 | potassium ion export(GO:0071435) potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.1 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.0 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.1 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.0 | 0.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.4 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.1 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.0 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.1 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.0 | 0.3 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.1 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 1.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.0 | 0.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.0 | GO:2000195 | gonadal mesoderm development(GO:0007506) negative regulation of female gonad development(GO:2000195) |
0.0 | 0.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.4 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.1 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.1 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 1.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0060761 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) negative regulation of response to cytokine stimulus(GO:0060761) |
0.0 | 0.1 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 0.2 | GO:0022008 | neurogenesis(GO:0022008) |
0.0 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.0 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
0.0 | 0.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.0 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.0 | 0.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.3 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 2.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.3 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.1 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.2 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 1.3 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.0 | 0.1 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.4 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.0 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.2 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
0.0 | 0.0 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.2 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.0 | 0.1 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.1 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.0 | 0.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.0 | 0.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.1 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.0 | 0.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.0 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.0 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.0 | 0.1 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.0 | 0.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.0 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.0 | 0.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.3 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.1 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.0 | 1.6 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.0 | 0.1 | GO:0007292 | female gamete generation(GO:0007292) |
0.0 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.1 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.0 | 0.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.0 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.2 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.0 | GO:0060348 | bone development(GO:0060348) |
0.0 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0044144 | modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.0 | 2.5 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.1 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.3 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.0 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 1.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.2 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.2 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.1 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.0 | 0.0 | GO:0072684 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.0 | 0.1 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.0 | 0.1 | GO:2000329 | peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.0 | 0.0 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.0 | 0.0 | GO:0008645 | hexose transport(GO:0008645) monosaccharide transport(GO:0015749) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.1 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.0 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.0 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.0 | 0.1 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.3 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.2 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.2 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.0 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.1 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.0 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.0 | 4.1 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 1.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 2.6 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
1.0 | 7.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.0 | 3.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
1.0 | 2.9 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.8 | 3.4 | GO:0031523 | Myb complex(GO:0031523) |
0.8 | 2.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.8 | 5.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.7 | 2.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.7 | 2.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.7 | 3.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.6 | 6.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 1.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 4.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 1.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.6 | 2.8 | GO:0002133 | polycystin complex(GO:0002133) |
0.6 | 2.2 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.5 | 2.7 | GO:0016938 | kinesin I complex(GO:0016938) |
0.5 | 2.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.5 | 2.1 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
0.5 | 2.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.5 | 5.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 0.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.5 | 2.0 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.5 | 2.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 1.4 | GO:0035101 | FACT complex(GO:0035101) |
0.5 | 8.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 0.5 | GO:0000806 | Y chromosome(GO:0000806) |
0.5 | 2.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 0.5 | GO:0044216 | host(GO:0018995) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.4 | 0.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.4 | 2.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.4 | 1.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.4 | 1.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 2.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 1.7 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.4 | 0.4 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.4 | 2.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.4 | 3.3 | GO:0014802 | terminal cisterna(GO:0014802) |
0.4 | 1.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.4 | 3.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 2.3 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.4 | 12.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 1.1 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.4 | 1.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 2.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 1.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 9.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 2.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 2.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 1.3 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.3 | 1.6 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.3 | 4.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.5 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.3 | 2.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 1.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 1.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.3 | 1.5 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.3 | 2.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 2.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 1.1 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 2.2 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.3 | 0.8 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.3 | 1.1 | GO:0099503 | secretory vesicle(GO:0099503) |
0.3 | 1.9 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 0.8 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 2.7 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 0.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.3 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 3.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 2.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 0.8 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.2 | 0.7 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.2 | 3.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 3.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.2 | 5.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.4 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 7.3 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.2 | 1.6 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 0.2 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.2 | 0.7 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.2 | 4.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.7 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.2 | 1.7 | GO:0097361 | CIA complex(GO:0097361) |
0.2 | 0.6 | GO:0036026 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.2 | 1.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.2 | 1.7 | GO:0016013 | syntrophin complex(GO:0016013) |
0.2 | 2.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.2 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.2 | 1.3 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.2 | 0.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 1.6 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 1.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 3.8 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 0.8 | GO:0005903 | brush border(GO:0005903) |
0.2 | 2.0 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 2.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 2.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.2 | 0.4 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 2.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 0.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.2 | 0.7 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.2 | 1.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 1.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 1.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 3.5 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 1.9 | GO:0098794 | postsynapse(GO:0098794) |
0.2 | 1.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.5 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 1.4 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 1.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 2.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.2 | 1.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 2.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 2.0 | GO:0070187 | telosome(GO:0070187) |
0.2 | 4.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 4.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.3 | GO:0019034 | viral replication complex(GO:0019034) |
0.2 | 1.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.6 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.5 | GO:0033011 | perinuclear theca(GO:0033011) |
0.2 | 2.3 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.5 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.2 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 4.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 5.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.6 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 0.8 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 4.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 0.6 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 4.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.9 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.1 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 13.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 1.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 3.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.1 | 5.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 3.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.6 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 1.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 1.4 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 1.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.4 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.1 | 2.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.7 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 9.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 11.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 14.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.5 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 14.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 7.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.5 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 0.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 5.6 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 1.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.5 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.5 | GO:0044753 | amphisome(GO:0044753) |
0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 1.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 1.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.5 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.1 | 1.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 10.2 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 1.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 13.2 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 6.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 8.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 10.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.2 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 7.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.5 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 2.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 4.4 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.1 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.6 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 1.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 1.4 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.6 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 1.5 | GO:0097433 | dense body(GO:0097433) |
0.1 | 1.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 2.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.5 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.2 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 11.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 3.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 1.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 12.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.4 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.1 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.1 | 0.7 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.1 | GO:0034448 | EGO complex(GO:0034448) |
0.1 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.1 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 1.5 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.1 | 1.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.3 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 0.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 5.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 1.4 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) AMPA glutamate receptor complex(GO:0032281) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 12.0 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.4 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.1 | 0.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.1 | 1.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 6.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 1.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 4.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 6.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 1.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.1 | 0.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 4.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.7 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.2 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.1 | 0.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.1 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 16.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 1.1 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 0.6 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.1 | 0.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 1.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 2.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 2.0 | GO:0098857 | membrane microdomain(GO:0098857) |
0.1 | 0.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 2.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 3.8 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 4.2 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 1.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 3.1 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.8 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.9 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 2.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.2 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.1 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 15.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 6.6 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.1 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 6.9 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 13.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.2 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.1 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 3.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 3.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 2.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 4.4 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.6 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 1.4 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 1.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 4.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.3 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 3.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 1.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 4.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 2.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.5 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 7.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 4.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 3.7 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 13.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 4.8 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 2.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 1.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.4 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 1.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.2 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 1.0 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.0 | 1.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 20.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.5 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.0 | 0.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 16.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 1.9 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
0.0 | 0.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 2.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.7 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 2.6 | GO:0031253 | cell projection membrane(GO:0031253) |
0.0 | 0.2 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 1.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.2 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.0 | 16.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 1.1 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.6 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 1.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 41.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 1.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.3 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0030677 | ribonuclease P complex(GO:0030677) |
0.0 | 1.1 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.1 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 0.3 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 90.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 1.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 2.8 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 15.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.0 | 0.0 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.2 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.7 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.4 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.0 | 0.5 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 2.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.5 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 0.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.6 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.0 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 0.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 1.2 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.6 | GO:0030017 | sarcomere(GO:0030017) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 7.0 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
1.3 | 3.9 | GO:0016730 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
1.2 | 3.7 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
1.2 | 8.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
1.0 | 8.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.0 | 5.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.9 | 4.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.9 | 2.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.9 | 5.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.8 | 2.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.8 | 2.5 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.8 | 2.5 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.8 | 2.5 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.8 | 2.5 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.8 | 4.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.8 | 3.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.8 | 2.3 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.8 | 2.3 | GO:0070984 | SET domain binding(GO:0070984) |
0.8 | 0.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.8 | 2.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.8 | 5.3 | GO:0042806 | fucose binding(GO:0042806) |
0.7 | 3.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.7 | 2.8 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.7 | 7.0 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.7 | 2.1 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
0.7 | 11.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.7 | 2.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.7 | 3.3 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.7 | 2.0 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.6 | 1.9 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.6 | 2.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 8.9 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.6 | 4.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.6 | 3.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 1.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.6 | 0.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.6 | 3.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.6 | 7.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 3.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.6 | 1.8 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.6 | 2.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 1.7 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.6 | 1.7 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.6 | 3.9 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.6 | 19.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.6 | 2.2 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.5 | 2.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.5 | 1.6 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.5 | 1.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 3.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 2.1 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.5 | 2.1 | GO:0050421 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.5 | 2.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.5 | 2.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.5 | 2.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.5 | 1.5 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.5 | 2.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.5 | 1.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.5 | 1.5 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.5 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 2.0 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.5 | 1.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 1.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 1.4 | GO:0032093 | SAM domain binding(GO:0032093) |
0.5 | 1.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 0.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.5 | 0.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.5 | 2.3 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.5 | 0.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.5 | 8.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.5 | 4.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.5 | 2.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 6.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 0.9 | GO:0070026 | nitric oxide binding(GO:0070026) |
0.4 | 1.3 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.4 | 9.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 1.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 1.3 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.4 | 1.7 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.4 | 1.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 0.8 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
0.4 | 2.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.4 | 2.5 | GO:1903135 | cupric ion binding(GO:1903135) |
0.4 | 1.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.4 | 1.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.4 | 2.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 0.8 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 0.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.4 | 2.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 11.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 4.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 1.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.4 | 2.8 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 1.6 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.4 | 4.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 1.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 2.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.4 | 1.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.4 | 1.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.4 | 3.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 3.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 1.9 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.4 | 3.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 1.5 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.4 | 3.8 | GO:0005497 | androgen binding(GO:0005497) |
0.4 | 1.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 1.1 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.4 | 1.9 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.4 | 1.5 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.4 | 4.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 4.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 5.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.4 | 8.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.4 | 4.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 2.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 3.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 4.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.3 | 2.4 | GO:0046979 | TAP2 binding(GO:0046979) |
0.3 | 1.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.3 | 2.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 13.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 1.0 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.3 | 1.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.3 | 1.0 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.3 | 1.3 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 3.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 0.7 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.3 | 1.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 1.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 1.0 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
0.3 | 6.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 9.0 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.3 | 1.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 2.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 4.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 1.3 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.3 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 2.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 1.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 6.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.9 | GO:0032450 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
0.3 | 0.3 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.3 | 2.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.3 | 3.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.5 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.3 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 1.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.3 | 1.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 0.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 3.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 1.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 0.9 | GO:0070364 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
0.3 | 6.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.9 | GO:0052830 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.3 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 0.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.3 | 2.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.3 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.3 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.7 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 4.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.3 | 2.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.3 | 0.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.3 | 1.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.3 | 1.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.3 | 0.8 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.3 | 1.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 1.9 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 0.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.3 | 3.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 0.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.3 | 1.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 6.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 3.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 0.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 5.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.3 | 3.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 2.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 0.8 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 0.8 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.3 | 1.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.3 | 5.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 10.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 0.8 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.3 | 1.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 0.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.3 | 1.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.3 | 1.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.3 | 1.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 2.0 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.2 | 0.7 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
0.2 | 2.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 1.0 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 1.0 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.2 | 2.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.7 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.2 | 0.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 2.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.2 | 1.0 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.2 | 1.0 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.2 | 2.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 2.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 1.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 8.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 1.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.7 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.2 | 0.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.2 | 1.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 3.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 4.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 2.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.7 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.2 | 0.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.7 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.2 | 1.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 1.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.2 | 0.7 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.2 | 0.7 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.2 | 1.6 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 2.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 2.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 1.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 2.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.7 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.2 | 7.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 2.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 2.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 2.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.2 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.2 | 0.6 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.2 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 0.6 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 7.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 1.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 5.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 1.0 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.2 | 0.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 2.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 4.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 1.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.2 | 5.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.2 | 1.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 2.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 3.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 1.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 1.4 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 4.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 2.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 1.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 2.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 7.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 6.6 | GO:0071617 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 0.6 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.2 | 1.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 2.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.2 | 0.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.0 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 1.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 1.0 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 0.6 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.2 | 1.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.2 | 0.8 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.8 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.2 | 0.8 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 0.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 1.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 1.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 1.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 2.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 0.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.4 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.2 | 1.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.7 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.2 | 2.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 1.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.9 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.2 | 0.9 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.2 | 0.5 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.2 | 2.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 0.5 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.2 | 1.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 1.1 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 0.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.2 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.2 | 0.7 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.2 | 0.4 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.2 | 1.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 4.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 0.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 0.9 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 1.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 0.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 3.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.7 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 2.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.5 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.2 | 0.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.2 | 0.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 6.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 4.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 4.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.7 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 0.5 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.2 | 5.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.7 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 1.0 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.2 | 3.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.3 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.2 | 0.3 | GO:0005503 | all-trans retinal binding(GO:0005503) |
0.2 | 1.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 1.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 4.5 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.5 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.2 | 2.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 4.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 1.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.2 | 0.5 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.2 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.9 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 6.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 5.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 1.6 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.2 | 1.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.5 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
0.2 | 0.6 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.2 | 0.5 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.2 | 3.9 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 6.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.4 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.1 | 0.4 | GO:0080084 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.1 | 0.6 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.7 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 36.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.6 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.4 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.1 | 1.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 2.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.9 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.1 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.4 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.1 | 7.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 2.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 11.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 1.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 3.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.4 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 0.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 1.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 3.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 4.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 1.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.1 | 4.7 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 1.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.8 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.8 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.9 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 0.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.1 | 1.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
0.1 | 3.8 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 1.2 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.5 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 6.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 0.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.4 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 2.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.1 | 1.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 3.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 5.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.4 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 9.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 1.0 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 2.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 1.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.1 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 2.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.4 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 3.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 5.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.4 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
0.1 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.6 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.1 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 1.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 1.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.3 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 4.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 1.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 4.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.8 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 2.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 1.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.9 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 1.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 1.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 1.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.7 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.1 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.8 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 0.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 19.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 1.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.3 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 1.6 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.3 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.2 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 1.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.3 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.1 | 4.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.4 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.5 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.1 | 1.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 5.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 1.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 3.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 1.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.3 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.1 | 0.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 3.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.1 | 6.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 5.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.3 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.1 | 0.3 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.1 | 1.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.1 | 0.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 2.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.4 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.1 | 2.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 11.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 1.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.1 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.3 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.1 | 0.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 1.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 2.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.3 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.1 | 0.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 1.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.9 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.2 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 1.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.6 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 1.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 2.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 3.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 2.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.2 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 0.3 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 4.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 7.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 1.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.3 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.1 | 1.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 5.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.3 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 5.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 14.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 2.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 2.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 0.9 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 2.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 13.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.4 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.1 | 3.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 2.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.5 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 4.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.3 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.2 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.1 | 3.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.6 | GO:0045502 | dynein binding(GO:0045502) dynein light intermediate chain binding(GO:0051959) |
0.1 | 5.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.1 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 9.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 2.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.9 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.6 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.3 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 1.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 3.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 1.0 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 14.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.8 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.2 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 1.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.2 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 2.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 0.3 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.2 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 1.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 33.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.5 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.2 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 3.4 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.2 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
0.1 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 1.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 1.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 11.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.0 | 0.3 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.0 | 6.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 1.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.0 | 3.1 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 1.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.5 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.1 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 3.4 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 1.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.2 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.0 | 0.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 1.1 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 2.6 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 1.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.0 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.0 | 0.0 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.0 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.6 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.1 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.1 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.0 | 0.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.0 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.0 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
0.0 | 0.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 2.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.1 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
0.0 | 0.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 1.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.0 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 4.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 1.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.0 | 0.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 1.3 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 1.5 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.0 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.0 | 0.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 1.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.7 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.6 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0072545 | tyrosine binding(GO:0072545) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.0 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 0.1 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.0 | 0.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0008431 | vitamin E binding(GO:0008431) |
0.0 | 0.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 1.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 19.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 9.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 1.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 2.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 21.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 17.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 6.5 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 6.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 4.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 12.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 7.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 6.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 13.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 2.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 5.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 1.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 4.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 12.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 3.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 7.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 2.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 12.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 2.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 6.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 6.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 2.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 2.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 6.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 8.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 3.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 9.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 9.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 3.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 3.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 30.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 5.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 2.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 5.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 6.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 6.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 13.2 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 5.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 6.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 8.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 7.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 5.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 3.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 2.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 5.2 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 6.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 4.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 26.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 4.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 9.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 5.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 3.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 3.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 6.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 8.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 3.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 3.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 10.8 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 1.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 1.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 2.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 5.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.6 | 12.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 1.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 1.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.5 | 9.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 0.9 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.5 | 3.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.4 | 40.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 14.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 12.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 12.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 5.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 16.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 5.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 1.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 12.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 4.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 4.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 1.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 5.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 3.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 12.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 9.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 6.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 5.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 8.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 6.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 3.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 3.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 8.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 4.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 4.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 0.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.2 | 4.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 5.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 3.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 9.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 2.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 9.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 11.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 4.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 7.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 2.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 7.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 4.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 6.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 1.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 14.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 1.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 5.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 7.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 6.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 3.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 3.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 4.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 4.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 1.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.4 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 2.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 6.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 3.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 5.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 5.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 2.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 5.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 5.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 5.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 3.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 2.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 4.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 2.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 4.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 6.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 2.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 14.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 3.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.2 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 2.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 2.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.9 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 7.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 4.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 6.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 2.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 8.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.5 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 10.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.6 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.4 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 1.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 5.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 3.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 4.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 8.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 4.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.3 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 1.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 6.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 2.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 2.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 6.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 1.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 3.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 1.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 2.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 1.0 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
0.0 | 0.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.6 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 0.0 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 1.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |